comparemela.com

Latest Breaking News On - Servier research - Page 1 : comparemela.com

Servier unveils its 2030 ambition and reveals a new visual identity (2)

PARIS, Oct. 6, 2022 /PRNewswire/ Servier today unveils its 2030 ambition as well as a new visual identity.

France generalUnited statesPrnewswire servierOlivier laureauServier researchDevelopment institute at parisOur groupSingle pill combinationsEastern europeDevelopment instituteArtificial intelligenceAnalytics link

Servier unveils its 2030 ambition and reveals a new visual identity (1)

A new ambition by 2030 to accelerate its transformation dynamic A visual identity, a marker of the.

France generalUnited statesPrnewswire servierOlivier laureauServier researchDevelopment institute at parisOur groupSingle pill combinationsEastern europeDevelopment instituteArtificial intelligenceAnalytics link

Servier unveils its 2030 ambition and reveals a new visual identity

/PRNewswire/ Servier today unveils its 2030 ambition as well as a new visual identity that reflects the transformation undertaken by the Group, bringing.

France generalUnited statesPrnewswire servierOlivier laureauServier researchDevelopment institute at parisOur groupSingle pill combinationsEastern europeDevelopment instituteArtificial intelligenceAnalytics link

#Call4 0Leaders | Michel Eschenbrenner (Servier Pharma Romania): We believe in the power of active collaboration as opposed to competition

Call For Leaders 4.0 - Another top business professional in Romania takes center stage under the #Call4.0Leaders spotlight! In this installment of Business Review special

France generalServier bioinnovationServier researchDevelopment instituteSustainable development goals of the united nationsRd departmentRd centersInternational centers for therapeutic researchDevelopment goalsTop employer europePharma romaniaTop employerLife cycle managementSingle pillChief medical officerPharmaceutical strategy

Focus on innovation: Servier sponsors Paris-Saclay SPRING!

Its research is focused on cardiovascular diseases, cancers, diabetes, immune-inflammatory and neuropsychiatric diseases.

France generalOlivier nosjeanAngelo paciServier researchSaclay core teamGustave roussy cancer instituteDevelopment instituteScientific affairsSaclay universityDigital technologiesInnovation trackGlobal headTranslational medicinePharmacology unitOpen innovationNormale sup

vimarsana © 2020. All Rights Reserved.